Cervical Dystonia Market to Witness Robust Growth During the Forecast Period (2026-2036) Driven by the Expanding Therapeutic Options | DelveInsight

The cervical dystonia market is expected to increase due to an increase in disease prevalence during the forecast period. Additionally, the expected launch of emerging therapies such as ABP-450 (prabotulinumtoxinA) (AEON Biopharma), IPN10200 (Ipsen), MTR-601 (Mitra Biosciences), VIM0423...